Ligand Appoints Pharmaceutical Executive Sarah Boyce to its Board of Directors

October 15, 2019 sandiegobiotech News Comments Off on Ligand Appoints Pharmaceutical Executive Sarah Boyce to its Board of Directors
Ligand Appoints Pharmaceutical Executive Sarah Boyce to its Board of Directors
/

SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) (?Ligand? or ?the Company?) announces the appointment of Sarah Boyce to the Company’s Board of Directors, effective today. Ms. Boyce currently serves as President and CEO of Avidity Biosciences, Inc., a privately held biotechnology company pioneering the use of antibody-oligonucleotide conjugates (AOC?) to treat rare muscle disorders and other serious diseases. Ms. Boyce’s appointment increases the number of Ligand d